Dr. Rodney Sappington has over 20 years of experience across AI/machine learning-driven technologies in medical diagnostics, drug discovery, multi-agent-based research, and advanced manufacturing of nanomaterials. He was one of the first to develop and deploy deep learning for early detection of high mortality cancers.
He has led world-class teams, founded and built companies, built AI/machine learning and software systems at scale. His experience is a rare combination of AI/machine learning, clinical science, and deep tech for high impact across healthcare, climate, and AI Alignment and Safety research.
